Diagnostics & Research Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1330 |  SHC Sotera Health Company - Common Stock | 17.48 USD | -3.00% | -1.52% | +9.11% | +3.68% | 4.98 B USD | ||
| 1717 |  GRAL GRAIL, Inc. - Common Stock | 68.76 USD | -0.04% | -1.16% | +9.06% | -30.55% | 2.95 B USD | ||
| 1979 |  NEOG Neogen Corporation - Common Stock | 9.25 USD | -1.49% | -0.64% | +0.65% | +76.53% | 2.01 B USD | ||
| 2061 |  NEO NeoGenomics, Inc. - Common Stock | 14.24 USD | -1.79% | -4.88% | +28.64% | +89.11% | 1.85 B USD | ||
| 2216 |  CDNA CareDx, Inc. - Common Stock | 27.56 USD | -2.65% | -5.78% | +23.75% | +84.84% | 1.42 B USD | ||
| 2220 |  PSNL Personalis, Inc. - Common Stock | 14.11 USD | +0.93% | +2.32% | +40.26% | +103.90% | 1.48 B USD | ||
| 2427 |  OPK Opko Health, Inc. - Common Stock | 1.41 USD | -5.37% | -7.84% | -1.40% | +3.68% | 1.06 B USD | ||
| 2644 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 5.52 USD | -1.78% | +3.37% | +25.17% | +283.33% | 770.94 M USD | ||
| 2691 |  CSTL Castle Biosciences, Inc. - Common stock | 23.64 USD | -0.80% | -4.33% | +16.45% | -3.94% | 717.00 M USD | ||
| 2817 |  FLGT Fulgent Genetics, Inc. - Common Stock | 20.61 USD | -1.95% | -1.01% | +11.65% | -12.78% | 585.34 M USD | ||
| 2862 |  MYGN Myriad Genetics, Inc. - Common Stock | 5.87 USD | +0.17% | -2.17% | +32.81% | -29.02% | 554.41 M USD | ||
| 3257 |  LAB Standard BioTools Inc. - Common Stock | 0.89 USD | -1.11% | +2.30% | +9.88% | -31.54% | 347.16 M USD | ||
| 3420 |  PRE Prenetics Global Limited - Class A Ordinary Share | 16.75 USD | -0.24% | -6.37% | -17.28% | +104.27% | 282.64 M USD | ||
| 3627 |  BDSX Biodesix, Inc. - Common Stock | 20.44 USD | +0.49% | -15.43% | +37.92% | +63.39% | 206.62 M USD | ||
| 3810 |  IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.79 USD | -2.84% | -15.82% | -16.70% | +47.38% | 154.67 M USD | ||
| 3891 |  BNR Burning Rock Biotech Limited - American Depositary Shares | 12.00 USD | +11.63% | +40.85% | +34.08% | -59.89% | 129.85 M USD | ||
| 3963 |  XGN Exagen Inc. - Common Stock | 4.37 USD | -8.96% | -7.22% | +2.82% | -37.39% | 105.58 M USD | ||
| 3971 |  STIM Neuronetics, Inc. - Common Stock | 1.55 USD | 0.00% | +14.81% | +23.02% | -54.68% | 107.86 M USD | ||
| 4300 |  DRIO DarioHealth Corp. - Common Stock | 7.25 USD | +2.40% | +5.53% | -2.29% | -35.09% | 53.01 M USD | ||
| 4365 |  PRPO Precipio, Inc. - Common Stock | 26.37 USD | +1.42% | +5.78% | +12.31% | +25.63% | 47.13 M USD |
Nachrichten Diagnostics & Research Stocks
Agilent erweitert HPLC-Säulen-Portfolio für die Biopharmazie
Cathie Wood: ARK trennt sich von AMD und investiert in SpaceX und X-Energy
VolitionRx veröffentlicht Daten zu prognostischer Lungenkrebs-Studie
Digi Power X meldet hohe Liquidität und peilt Umsatz von 250-300 Mio. Dollar an
Wachstum durch KI-Wirkstoffforschung: Argus erhöht Kursziel für IQVIA Aktie
Hohe Bewertung: Jefferies stuft Medpace-Aktie ab
Natera: Rechtsvorstand Daniel Rabinowitz verkauft Aktien im Wert von 4,57 Mio. US-Dollar
Gainers Diagnostics & Research Stocks
BNR Burning Rock Biotech Limited - American Depositary Shares | 12.00 | +11.63% |
 MDXH MDxHealth SA - American Depositary Shares | 0.49 | +4.26% |
DRIO DarioHealth Corp. - Common Stock | 7.25 | +2.40% |
 BLLN BillionToOne, Inc. - Class A common stock | 120.10 | +1.75% |
PRPO Precipio, Inc. - Common Stock | 26.37 | +1.42% |
 STRR Star Equity Holdings, Inc. - Common Stock | 11.10 | +1.19% |
PSNL Personalis, Inc. - Common Stock | 14.11 | +0.93% |
BDSX Biodesix, Inc. - Common Stock | 20.44 | +0.49% |
Losers Diagnostics & Research Stocks
XGN Exagen Inc. - Common Stock | 4.37 | -8.96% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 0.76 | -8.43% |
 VNRX VolitionRX Limited Common Stock | 1.28 | -7.91% |
 NDRA ENDRA Life Sciences Inc. - Common Stock | 4.65 | -6.06% |
OPK Opko Health, Inc. - Common Stock | 1.41 | -5.37% |
 ADVB Advanced Biomed Inc. - Common Stock | 5.08 | -5.05% |
 XWEL XWELL, Inc. - Common Stock | 0.91 | -4.21% |
 GH Guardant Health, Inc. - Common Stock | 156.16 | -4.15% |